Zhejiang Shengda Bio-Pharm Co (SHSE:603079) YoY EBITDA Growth : 30.30% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Shengda Bio-Pharm Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Zhejiang Shengda Bio-Pharm Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 30.30%.

Zhejiang Shengda Bio-Pharm Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.04.

Zhejiang Shengda Bio-Pharm Co YoY EBITDA Growth Historical Data

The historical data trend for Zhejiang Shengda Bio-Pharm Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Shengda Bio-Pharm Co YoY EBITDA Growth Chart

Zhejiang Shengda Bio-Pharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

25.51

139.30

-48.30

-31.54

-72.64

Zhejiang Shengda Bio-Pharm Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-77.55	-127.21	-61.02	-336.56	30.30

Zhejiang Shengda Bio-Pharm Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Zhejiang Shengda Bio-Pharm Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(0.171	-	0.625)	/	\| 0.625 \|
=	-72.64 %

Zhejiang Shengda Bio-Pharm Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(0.043	-	0.033)	/	\| 0.033 \|
=	30.30 %

Zhejiang Shengda Bio-Pharm Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Zhejiang Shengda Bio-Pharm Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Shengda Bio-Pharm Co Ltd (SHSE:603079) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

N/A

Address

No.789, Renmin East Road, Chicheng Street, Tiantai County, Zhejiang Province, Hangzhou, CHN, 317200

Website

http://www.sd-pharm.com

Zhejiang Shengda Bio-Pharm Co Ltd is a pharmaceutical company. It is mainly engaged in the research and development, and production of biotin and biological preservatives. Its product portfolio includes biotin, folic acid and other vitamin products, as well as nisin and natamycin.

Executives

Pang Ai Ming	Director
Zhu Yong Gang	Director

Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Headlines

No Headlines